Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
NEW YORK (Reuters Health) – In a Korean study of patients with advanced non-small-cell lung cancer who had never smoked and were previously treated with platinum-based chemotherapy, progression-free…
NEW YORK (Reuters Health) – After 20 weeks of use, laropiprant continues to reduce flushing related to niacin treatment for a further 12 weeks, according to a study…
NEW YORK (Reuters Health) – Patients with sterile urine before undergoing shock wave lithotripsy can forgo antibiotic prophylaxis, according to the results of a meta-analysis reported in the…
NEW YORK (Reuters Health) – Rather than a 24-hour urine collection to measure proteinuria, a 12-hour urine protein determination and the protein:creatinine ratio can be used for evaluating…
NEW YORK (Reuters Health) – When ventilator-associated pneumonia (VAP) is suspected, the absence of Gram staining on a respiratory specimen reliably rules out the diagnosis. On the other…
NEW YORK (Reuters Health) – Rates of maternal morbidity among women with gestational hypertension are lowest when labor is induced at 38 weeks while neonatal morbidity/mortality rates are…
NEW YORK (Reuters Health) – Sialendoscopy is safe and effective for the treatment of obstructive diseases of the salivary glands in adults, according results of a systematic review…
NEW YORK (Reuters Health) – In clinical practice, XIENCE V everolimus-eluting coronary stent is associated with low event rates at one year, according to a large post-marketing study.…
NEW YORK (Reuters Health) – As a treatment for primary dysmenorrhea, continuous oral contraceptives (OCs) outperform cyclic oral contraceptives, but this advantage is lost after 6 months, according…
NEW YORK (Reuters Health) – Patients with inflammatory joint disease (IJD), including rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis, respond as well to statin therapy as those without…